Literature DB >> 20050017

Words of wisdom. Re: Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven. Attard G, Reide AHM, Yap TA, Raynaud F, Dowsett M, Settatree S, Barrett M, Parker C, Martins V, Folkerd E, Clark J, Cooper C, Kaye S, Dearnaley D, Lee G, de Bono JS. J Clin Oncol 2008;26:4563-71.

Mario A Eisenberger1.   

Abstract

Entities:  

Year:  2009        PMID： 20050017     DOI： 10.1016/j.eururo.2008.09.035

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  8 in total

Review 1.  Small molecule inhibitors as probes for estrogen and androgen receptor action.

Authors:  David J Shapiro; Chengjian Mao; Milu T Cherian
Journal:  J Biol Chem       Date:  2010-12-13       Impact factor: 5.157

2.  Synthesis of halogenated pregnanes, mechanistic probes of steroid hydroxylases CYP17A1 and CYP21A2.

Authors:  Francis K Yoshimoto; Melissa C Desilets; Richard J Auchus
Journal:  J Steroid Biochem Mol Biol       Date:  2011-10-05       Impact factor: 4.292

Review 3.  Managing Metastatic Castration-Resistant Prostate Cancer in the Pre-chemotherapy Setting: A Changing Approach in the Era of New Targeted Agents.

Authors:  Zafeiris Zafeiriou; Anuradha Jayaram; Adam Sharp; Johann S de Bono
Journal:  Drugs       Date:  2016-03       Impact factor: 9.546

4.  Atmospheric pressure photoionization tandem mass spectrometry of androgens in prostate cancer.

Authors:  Fred Bjørn Lih; Mark A Titus; James L Mohler; Kenneth B Tomer
Journal:  Anal Chem       Date:  2010-07-15       Impact factor: 6.986

5.  Small-Molecule-Mediated Degradation of the Androgen Receptor through Hydrophobic Tagging.

Authors:  Jeffrey L Gustafson; Taavi K Neklesa; Carly S Cox; Anke G Roth; Dennis L Buckley; Hyun Seop Tae; Thomas B Sundberg; D Blake Stagg; John Hines; Donald P McDonnell; John D Norris; Craig M Crews
Journal:  Angew Chem Int Ed Engl       Date:  2015-06-17       Impact factor: 15.336

6.  Unraveling the complexities of androgen receptor signaling in prostate cancer cells.

Authors:  Hannelore V Heemers; Donald J Tindall
Journal:  Cancer Cell       Date:  2009-04-07       Impact factor: 31.743

7.  Antineoplastic Isoflavonoids Derived from Intermediate ortho-Quinone Methides Generated from Mannich Bases.

Authors:  Mykhaylo S Frasinyuk; Galyna P Mrug; Svitlana P Bondarenko; Volodymyr P Khilya; Vitaliy M Sviripa; Oleksandr A Syrotchuk; Wen Zhang; Xianfeng Cai; Michael V Fiandalo; James L Mohler; Chunming Liu; David S Watt
Journal:  ChemMedChem       Date:  2016-02-17       Impact factor: 3.466

8.  Tumour responses following a steroid switch from prednisone to dexamethasone in castration-resistant prostate cancer patients progressing on abiraterone.

Authors:  D Lorente; A Omlin; R Ferraldeschi; C Pezaro; R Perez; J Mateo; A Altavilla; Z Zafeirou; N Tunariu; C Parker; D Dearnaley; S Gillessen; J de Bono; G Attard
Journal:  Br J Cancer       Date:  2014-10-14       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.